This study aimed to predict the molecular targets of cipargamin in humans and estimate the structural dynamics and binding affinity of their interactions compared to that of Plasmodium falciparum P-type ATPase 4 (PfATP4). In silico methods were used in this study which include target prediction, structure modeling and dynamics, and molecular docking. The results showed that cipargamin had 100% probability of binding to the human adenosine A3 receptor (ADORA3) and about 15% for other human targets which include tyrosine-protein kinase JAK2, adenosine A2a receptor, phosphodiesterase 5A and cathepsin K. The results of molecular docking showed that binding energy of cipargamin to PfATP4 and hADORA3 were-12.40 kcal/mol-1 and-13.40 kcal/mol-1 respectively. The docking was validated by the binding of enprofylline and fostamatinib to PfATP4 and hADORA3. Overall, the binding of cipargamin was closely similar to that of fostamatinib. This study shows the potential of cipargamin to modulate the activities of PfATP4 of the parasite (P. falciparum) as well as ADORA3 of the host (Homo sapiens). All the previous studies of cirpagamin have not implicated its action on hADORA3, thus this study provides an insight into a possible role of hADORA3 in the mechanism of malarial infection.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
3
Iseoluwa Isaac Ajayi, Toluwase Hezekiah Fatoki, Ayodele Sunday Alonge, Courage Dele Famusiwa, Ibrahim Olabayode Saliu, Blessing Anuoluwapo Ejimadu, Mayowa Oluwalana Obafemi
(2025)
Revisiting Plasmodium falciparum P-type ATPase 4 in malarial: ADMET, mutation effect, and molecular simulation studies of potential inhibitors
Journal of Biomolecular Structure and Dynamics, 43(12)
10.1080/07391102.2025.2516757
Toluwase Hezekiah Fatoki, Tosin Christianah Balogun, Adebayo Emmanuel Ojewuyi, Aduragbemi Christianah Omole, Oluwaseun Victor Olukayode, Afolasade Precious Adewumi, Adanne Joy Umesi, Nwadinma Priscillia Ijeoma, Abibat Esther Apooyin, Chinecherem Perpetual Chinedu, Ibukun Esther Idowu, Momoh Jimoh Isah
(2024)
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
BMC Pharmacology and Toxicology, 25(1)
10.1186/s40360-024-00804-z
Pratyusa Biswas, Rini Roy, Kuldip Ghosh, Debjani Nath, Asmita Samadder, Sisir Nandi
(2024)
To quest new targets of Plasmodium parasite and their potential inhibitors to combat antimalarial drug resistance
Journal of Parasitic Diseases, 48(4)
10.1007/s12639-024-01687-xThe statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.